- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06078124
Sibling-Support for Adolescent Girls (SSAGE)
November 14, 2025 updated by: Washington University School of Medicine
Sibling-Support for Adolescent Girls (SSAGE): A Whole-family, Gender Transformative Approach to Preventing Mental Illness Among Forcibly Displaced Adolescent Girls
Forcibly displaced adolescents face increased risks for mental illness and distress, with adolescent girls disproportionately affected in part due to the heightened gender inequity that often accompanies forced displacement.
Although the family unit has the potential to prevent mental illness and promote healthy development in adolescents, few family interventions have employed a gender transformative approach or included male siblings in an effort to maximize benefits for adolescent girls.
Therefore, the investigators propose to assess an innovative whole-family and gender transformative intervention-Sibling Support for Adolescent Girls in Emergencies (SSAGE)-to prevent mental health disorders among adolescent girls in Colombia who were recently and forcibly displaced from Venezuela.
The proposed R34 study will adapt the SSAGE curriculum through human-centered design with a range of stakeholders, including Venezuelan refugees, Colombian returnees and relevant civil society organizations.
The proposed study will then employ a hybrid type 1 effectiveness-implementation pilot randomized control trial (RCT) to test the program's effectiveness and mechanistic pathways as well as to explore determinants of implementation in order to establish the feasibility, acceptability, and fidelity of SSAGE.
To address these aims, the investigators will enroll 180 recently arrived, forcibly displaced adolescent girls in an RCT and examine the program's effectiveness on the prevention of mental illness (through reduction in anxiety, depression, interpersonal sensitivity, and somatization symptoms) one-month post-intervention.
The investigators will use contextually adapted and piloted measures to collect additional data on the hypothesized mechanistic pathways, including family attachment, gender equitable family functioning, self-esteem, and coping strategies.
The implementation evaluation will employ mixed methods to assess the program's feasibility, acceptability, fidelity and barriers and facilitators to successful implementation.
Potential findings can support humanitarian program implementation, as well as inform policy to support adolescent girls' mental health and to prevent the myriad disorders that can arise as a result of exposure to displacement, conflict, and inequitable gender norms in their households and communities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
186
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bogotá, Colombia
- Los Andes University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Live with a male and female caregiver and an adolescent male sibling or relative
- Immigrated to Colombia within the last year
- Are available, along with their family members, to participate in the SSAGE intervention for three months
- Are available to participate in survey questionnaires immediately before and one month after the intervention
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sibling Support for Adolescent Girls in Emergencies (SSAGE)
Participants in this arm will participate in the Sibling Support for Adolescent Girls in Emergencies (SSAGE) intervention, along with three family members, for twelve weeks
|
The Sibling Support for Adolescent Girls in Emergencies (SSAGE) intervention is a gender-transformative, 12-week program utilizing a "whole family approach" wherein an adolescent girl, her male sibling, and a male and female caregiver participate in sessions that are age- and gender-specific and combined with family-wide discussions of session learnings.
The sessions are interactive, engaging, and promote self-reflection and discussion on topics such as power, gender, interpersonal communication, and healthy relationships.
Given the whole-family approach, SSAGE addresses intersections between spousal relationships, caregiver-child relationships, and relationships between siblings, as they pertain to supporting the mental health and psychosocial well-being of adolescent girls.
Other Names:
|
|
No Intervention: Control arm
Care as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Level 1 Cross-Cutting Symptom
Time Frame: Up to 2 weeks following the end of the 12 week intervention
|
This measure initially includes 25 items and assesses the presence and severity of several psychiatric symptom domains in children and adolescents over the last two weeks.
19 of the items are rated on a 5-point scale (0=none/never; 1=slight/rare; 2=mild/several days; 3=moderate/more than half the days; and 4=severe/almost daily).
Questions on suicide ideation, suicide attempts, and substance use are rated on a 2-point scale of yes/no.
The included symptoms represent 12 domains of mental disorders: somatic symptoms, sleep problems, inattention, depression, anger/irritability (measured together), mania, anxiety, psychosis, repetitive thoughts and behaviors, substance use, and suicide ideation/attempts.
Generally, a respondent is flagged as requiring further inquiry for a given domain if they answered '2' or higher on at least one of the symptoms in each respective domain.
As such, this outcome is operationalized as 12 dichotomous variables reflecting the 12 domains.
|
Up to 2 weeks following the end of the 12 week intervention
|
|
Revised Children's Anxiety and Depression Scale (RCADS)-25
Time Frame: Up to 2 weeks following the end of the 12 week intervention
|
This scale assesses symptoms of depression and anxiety over the past two weeks in children and adolescents using 25 items.
Items are scored on a 4-point scale (0-never; 1-sometimes; 2-often; and 3-always) for the last two weeks.
The sum of all item scores are then converted into t-scores based on gender and age.
Ranges are as follows: t-score<65 is normal range; >=65 and <=69 is borderline clinical; and >=70 is clinical range.
|
Up to 2 weeks following the end of the 12 week intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Family Attachment and Changeability Index (FACI-8) (Modified)
Time Frame: Up to 2 weeks following the end of the 12 week intervention
|
We employed a modified version of the FACI8.
The FACI8 is traditionally a 16-item scale where each item is scored using a 4-point Likert scale of how frequently the event occurs in the last 2 weeks (1-Never; 2-Sometimes; 3-Most of the time; 4-Always).
During baseline training, it was determined that four of the items in the traditional FACI8 were not reliable or valid in our study setting.
As such, a 12-item version was employed.
The modified FACI8 consists of two subscales: Attachment and Changeability.
The attachment subscale includes 7 items and the changeability subscale comprises 5 items.
Subscale scores are created by summing the relevant item responses.
Unfortunately, there was a tech issue with one of the changeability items at endline and data were not collected for that item.
As such, we removed that item from the changeability subscale to preserve comparability with baseline.
The final score for attachment can be 7-28 and changeability from 4-16.
Higher scores are better.
|
Up to 2 weeks following the end of the 12 week intervention
|
|
Rosenberg Self-Esteem Scale
Time Frame: Up to 2 weeks following the end of the 12 week intervention
|
The Rosenberg Self-Esteem Scale is a 10-item scale that measures positive and negative feelings about the self to create a measure of overall self-worth.
Items are scored using a 4-point Likert scale signaling level of agreement with each statement, from strongly agree to strongly disagree.
Five items are reverse coded.
The final score can take a value from 10 to 40, with higher scores indicating greater self-esteem.
The scale asks about the last two weeks and the measure was taken up to 2 weeks following the end of the 12 week intervention.
|
Up to 2 weeks following the end of the 12 week intervention
|
|
Kidcope
Time Frame: A stressor that occurred in the last two weeks; measurement taken up to 2 weeks following the end of the 12 week intervention
|
Kidcope is a 15-item checklist designed to measure cognitive and behavioural coping in children and adolescents.
It measures the frequency of 15 coping strategies, including: problem-solving, distraction, social support, social withdrawal, cognitive restructuring, self-criticism, blaming others, emotional expression, wishful thinking and resignation.
Items rare scored on a 4-point scale (0 = "Not at all" to 3 = "Almost all the time").
The final measure is operationalized as 15 dichotomous indicators, where a '1' signals the participant used that coping strategy at least sometimes in the last two weeks for a stressor and a '0' means the participant never used the coping mechanism in the last two weeks.
|
A stressor that occurred in the last two weeks; measurement taken up to 2 weeks following the end of the 12 week intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Lindsay Stark, DrPH, Washington University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 5, 2024
Primary Completion (Actual)
December 30, 2024
Study Completion (Actual)
June 30, 2025
Study Registration Dates
First Submitted
September 28, 2023
First Submitted That Met QC Criteria
October 5, 2023
First Posted (Actual)
October 11, 2023
Study Record Updates
Last Update Posted (Actual)
November 21, 2025
Last Update Submitted That Met QC Criteria
November 14, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Behavior
- Anxiety Disorders
- Depression
- Mental Disorders
- Organization and Administration
- Health Services Administration
- Health Services
- Health Care Facilities Workforce and Services
- Hospital Administration
- Health Facility Administration
- Health Facilities
- Emergency Medical Services
- Hospital Departments
- Emergency Service, Hospital
Other Study ID Numbers
- R34MH134078-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified questionnaire data will be shared beginning 3 months and ending 5 years following article publication with qualified researchers who have a research question appropriate to the data and of potential benefit to forcibly displaced adolescent girls.
Deidentified data will only be provided in aggregate after completion of a data use agreement.
Requests should be directed to lindsaystark@wustl.edu.
The protocol and statistical analysis plan will be made available on Clinicaltrials.gov
only as required by federal regulation or as a condition of awards and agreements supporting the research.
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following article publication.
IPD Sharing Access Criteria
Qualified researchers who have a research question appropriate to the data and of potential benefit to forcibly displaced adolescent girls will be granted access to the data.
Requests should be directed to lindsaystark@wustl.edu.
Deidentified data will only be provided in aggregate after completion of a data use agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Sibling Support for Adolescent Girls in Emergencies
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Obesity
-
Oregon Research InstituteCompleted
-
Population Services InternationalFederal Democratic Republic of Ethiopia Ministry of Health; Addis Ababa University...Not yet recruitingAdolescent Health | HPV Vaccine Acceptability | HPV Vaccines | Integrated Community-based Intervention Package | Papillomavirus Vaccines | HPV Vaccine Attitudes | Adolescent Health Services | HPV Vaccinations | HPV Vaccine Knowledge
-
Cornell UniversityRecruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Childhood Obesity | Metabolic Disease | Behavior, AdolescentUnited States
-
The National Center on Addiction and Substance...RecruitingSubstance Use Disorders | Internalizing DisordersUnited States
-
Trustees of Dartmouth CollegeNot yet recruitingAnxiety Disorders | Anxiety | Anxiety Disorder of Childhood
-
University of California, Los AngelesBodiMojo, Inc.CompletedChronic Pain | Parents | Pediatric DisorderUnited States
-
Ostfold University CollegeActive, not recruiting
-
West Chester University of PennsylvaniaBill and Melinda Gates Foundation; University of South Carolina; University of... and other collaboratorsCompletedMental Health Disorder | Social Isolation | Stigma, SocialUnited States
-
University of AarhusLundbeck Foundation; TrygFonden, Denmark; Sygekassernes HelsefondCompleted